A Randomized, Double-blind, Active-controlled, Multicenter Phase3 Trial to Evaluate the Efficacy and Safety of Co-administrated Temisartan/Amlodipine and Rosuvastatin in Subjects With Hypertension and Hyperlipidemia
Phase of Trial: Phase III
Latest Information Update: 29 Apr 2017
At a glance
- Drugs Amlodipine/rosuvastatin/telmisartan (Primary) ; Amlodipine/telmisartan; Rosuvastatin
- Indications Hyperlipidaemia; Hypertension
- Focus Therapeutic Use
- Sponsors Yuhan
- 13 Apr 2017 Status changed from planning to recruiting.
- 30 Nov 2016 New trial record
- 31 Oct 2016 According to an Yuhan media release, this trial will start as early as in November.